Collegium Pharmaceutical, Inc. COLL Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s change in AR?
- Collegium Pharmaceutical, Inc. (COLL) reported change in AR of $17.43M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s change in AR changed year-over-year?
- Collegium Pharmaceutical, Inc.'s change in AR increased by 10155.3% year-over-year, from $170K to $17.43M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.